December 2024 in “Ukrains kyi Visnyk Psykhonevrolohii” This study found that women with mixed alopecia experienced significant cognitive impairments, particularly those with adaptation disorders, with symptoms like rapid fatigue and impaired concentration being most prevalent. The cognitive patterns are complex and require further investigation to inform tailored rehabilitation strategies.
September 2024 in “Journal of Microbiology and Biotechnology” In this study, the researchers found that their conductive bio-harvesting tonic enhanced hair follicle proliferation and delayed regression with electric stimulation and the antifungal agent 6-pentyl-α-pyrone in both mice and human hair follicle tests.
September 2024 in “Journal of Drugs in Dermatology” This review found that various dermatological procedures for Seborrheic Dermatitis, such as phototherapy and laser treatments, showed significant efficacy in small cohorts with high patient satisfaction, but highlighted the need for further research to standardize protocols and evaluate long-term outcomes.
August 2024 in “Journal of the Association of Physicians of India” This study examined 1,992 patients at a hospital in India for signs of B12 deficiency and found common symptoms included hair loss, poor memory, and weakness. The study also reported that adding vitamin B12 powder to prepared food could improve blood levels of the vitamin.
July 2024 in “Clinical Case Reports” In this case study, a 25-year-old presented with symptoms of lupus but tested negative for antinuclear antibodies, complicating diagnosis. The researchers emphasize that comprehensive diagnostic approaches, beyond ANA testing, are vital for effectively identifying and treating lupus nephritis to avoid serious outcomes.
June 2024 in “Current Developments in Nutrition” This study found that a nutritional intervention in dogs led to changes in skin microbiome and immune-related gene expression, with reduced levels of certain fungal pathogens and a potential alleviation of atopic dermatitis symptoms.
June 2024 in “Kerala Journal of Ayurveda” In this case report, an 18-year-old male with alopecia areata showed significant hair regrowth after six weekly treatments with Pracchana, accompanied by the external application of Indraluptha mashi and Malathyadi kera, suggesting these interventions may be effective for managing spot baldness.
June 2024 in “Ukrains kyi Visnyk Psykhonevrolohii” This study found that among women with diffuse alopecia, depressive symptoms were common, affecting more than a third of patients, particularly those with mixed alopecia, where the prevalence was three times higher compared to metabolic alopecia.
May 2024 in “Pharmacia/Farmaciâ” In this study, Ipomoea batatas leaf extracts exhibited significant hair growth stimulation and strong antifungal activity against Malassezia furfur, potentially offering a promising treatment for alopecia with further research needed on their androgen receptor inhibition potential.
The researchers in this study observed that while hair chemical use was common among females with SLE, it was not linked to the development of SLE. However, those who used chemical hair straighteners before their SLE diagnosis had a higher risk of developing cutaneous manifestations.
April 2024 in “Journal of clinical medicine research” This review discusses seborrheic alopecia in young people, its possible link to fungal infections, and suggests that Malassezia spp. flora may play a key aetiologic role.
March 2024 in “Korean Journal of Pharmacognosy” This study found that Nymphaea caerulea flower extract may improve scalp condition by reducing sebum production, inhibiting inflammation and microbial factors, and decreasing cortisol and vascular permeability.
March 2024 in “Poster presentations” This case report describes a 43-year-old woman diagnosed with both Kikuchi-Fujimoto disease and systemic lupus erythematosus, who showed clinical improvement after treatment with glucocorticoids and hydroxychloroquine, highlighting the rare coexistence of these conditions and the ongoing uncertainty about the precise cause of Kikuchi-Fujimoto disease.
February 2024 in “Internet Journal of Rheumatology and Clinical Immunology” This study examines a diagnostic case of SLE with atypical symptoms linked to thymoma-related multiorgan autoimmunity.
January 2024 in “Journal of Dermatology & Cosmetology” This study found that the ThriveCo Anti-Dandruff Pre-Shampoo Treatment, containing ZenscalpinTM, significantly reduced dandruff by 54.79% after 8 days and improved scalp health, with most participants reporting reduced flaking, dryness, and itchiness, and no noted adverse events.
January 2024 in “Ankara City Hospital Medical Journal” This case report describes a 42-year-old woman with Rhupus, a rare overlap syndrome of rheumatoid arthritis and systemic lupus erythematosus, highlighting challenges in diagnosis due to non-specific clinical criteria and documenting specific symptoms such as inflammatory arthritis, malar rash, and hematological abnormalities observed during follow-up.
January 2024 in “Open Journal of Veterinary Medicine” In this study on dogs with yeast imbalances and dermatological signs, a protocol using chlorhexidine and Ophytrium products significantly reduced Malassezia pachydermatis counts and improved pruritus and irritation scores over 21 days, earning positive assessments from veterinarians and owners in most cases.
December 2023 in “Curēus” In this case study, a 36-year-old female with severe lupus enteritis and intestinal pseudo-obstruction showed significant clinical improvement after treatment with intravenous methylprednisolone, hydroxychloroquine, and cyclophosphamide, highlighting the complexities and challenges in diagnosing and managing atypical lupus manifestations.
September 2023 in “International journal of drug delivery technology” This study developed and tested an herbal shampoo containing tea, ashwagandha, sandalwood, and nagarmotha, finding it exhibited good cleansing properties and effectively controlled Candida and Malassezia fungi.
September 2023 in “Current opinion in microbiology” This source discusses how the skin mycobiome, dominated by Malassezia fungi, may provide a unique niche that can be disrupted by environmental changes, potentially leading to the fungal pathogen C. auris overtaking Malassezia and predisposing individuals to severe infections.
September 2023 in “International Journal of Cosmetic Science” The researchers observed that two non-antimicrobial shampoos caused a significant increase in fungal germs but did not affect the overall scalp microbiota diversity over two weeks, suggesting these formulations may preserve or stimulate the scalp microbiota without adverse effects.
September 2023 in “Clinical, cosmetic and investigational dermatology” In this study, the researchers found that a 28-day topical treatment with a postbiotic ferment complex notably altered the scalp microbiome in women with sensitive scalps, increasing certain bacterial species and decreasing others, while also reportedly alleviating symptoms of sensitive skin syndrome in all participants.
September 2023 in “Journal of the American Academy of Dermatology” The hair care routine effectively improved scalp health and reduced fungus in children with kinky hair.
August 2023 in “International Journal of Dermatology” This study used a Lebanese national registry to document dermatologic symptoms related to COVID-19 and its vaccines, noting that urticaria and telogen effluvium were common during infection, while urticaria and herpes zoster were notable post-vaccination.
August 2023 in “The American Journal of Medicine” This case report describes a 17-year-old female patient diagnosed with systemic lupus erythematosus, presenting with arthralgia, hair loss, and Raynaud's phenomenon. The diagnosis was supported by elevated ESR and positive autoantibodies, and treatment included hydroxychloroquine and prednisone.
July 2023 in “Institutional Repositories DataBase (IRDB)” Malassezia species may contribute to hair loss in AGA patients.
July 2023 in “Journal of Ayub Medical College Abbottabad” This case study details a 30-year-old woman diagnosed with Lupus Vasculitis, presenting with symptoms like intermittent fever, joint pain, and respiratory issues, after tests revealed specific antibody patterns and reduced complement levels, leading to treatment with steroids, mycophenolate mofetil, and hydroxychloroquine.
June 2023 in “Pediatric investigation” This case report describes a 7-year-old boy with pityriasis versicolor presenting as scalp hypopigmentation, a rare distribution for this fungal infection. Diagnosis was confirmed via Wood's lamp examination and microscopy, and the condition resolved after treatment with topical terbinafine hydrochloride cream.
June 2023 in “Deleted Journal” This study found that all healthy cats tested were carriers of *Microsporum canis*, and 86.66% of dogs carried this fungus, with further positive cultures for other dermatophytes and yeasts suggesting these animals may contribute to environmental fungal spread.
June 2023 in “Journal of Biosciences and Health” This study found that all tested cats and 86.66% of dogs were carriers of dermatophytes like Microsporum canis, with cats showing higher prevalence, indicating these asymptomatic animals may significantly contribute to the spread of dermatophytosis and dermatomycoses.